Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucuronidase, beta pseudogene" refers to a **pseudogene** related to the gene encoding beta-glucuronidase (GUSB). Pseudogenes are DNA sequences resembling functional genes but are non-coding and generally do not produce active proteins. As such, this entity is not a source of active enzyme, has no established biological or pathological role, and is not considered a therapeutic target or biomarker[6]. If your intent was to retrieve information about the functional enzyme, the appropriate gene is **beta-glucuronidase (GUSB)**, not the pseudogene. The pseudogene itself is not a valid therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucuronidase, beta pseudogene.